Conservation International Announces New CEO and New Interim Chairman of the Board to Lead Global Progress on Nature Conservation for People
Senior Global Conservation Leader Dr. Sebastian Troëng named CEO; Former EPA Administrator,…
Coloplast A/S – Interim Financial Report, Q1 2025/26
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast…
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale…
Ranch Origin Investment Management Ltd Releases Annual Operations Report Highlighting Investment Support and Interim Progress in Sustainable Ranching
Denver, Colorado, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Ranch Origin Investment Management…
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.…
Interim Report January September 2025
Interim Report January – September 2025 Third Quarter 2025 (compared to third…
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
November 18, 2025 16:30 ET | Source: Protara Therapeutics NEW YORK, Nov.…
Sonata Software Consolidated PAT grew by 10% QoQ, Declares second interim dividend of 1.25 per share
MUMBAI, India, Nov. 13, 2025 /PRNewswire/ -- Sonata Software (NSE: SONATSOFTW) (BSE:…
NTG Nordic Transport Group publishes interim report for Q3 2025
Company announcement no. 10 – 25 10 November 2025 NTG Nordic Transport…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
